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Abstract Infectious diseases caused by antimicrobial-
resistant microbes (ARMs) and the treatment are the seri-
ous problems in the field of medical science today world
over. The development of alternative drug line to treat such
infectious diseases is urgently required. Researches on
ARMs revealed the presence of membrane proteins
responsible for effusing the antibiotics from the bacterial
cells. Such proteins have successfully been treated by
plant-derived antimicrobials (PDAms) synergistically along
with the commercially available antibiotics. Such syner-
gistic action usually inhibits the efflux pump. The enhanced
activity of plant-derived antimicrobials is being researched
and is considered as the future treatment strategy to cure
the incurable infections. The present paper reviews the
advancement made in the researches on antimicrobial
resistance along with the discovery and the development of
more active PDAms.
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Introduction
Increasing antimicrobial resistance (AMR) among
microbes caused the emergence of new resistant pheno-
types and further caused the development of new antimi-
crobial compounds (Goossens 2013). Infectious diseases
caused by antimicrobial-resistant microbes (ARM) have
been frequently reported since last few years (Vila and Pal
2010). About 440,000 new cases of multidrug-resistant
tuberculosis (MDR-TB) are recorded annually, causing
approximately 150,000 deaths all over the world. Recently,
a joint meeting of medical societies, the first ever in India
was held to tackle the challenges of antimicrobial resis-
tance in developing world (Ghafur 2013). As a result of this
conference ‘‘Chennai declaration’’ came into existence,
initiating efforts through a national policy to control the
rising trend of AMR in India and abroad (Ghafur et al.
2012).
Multidrug-resistant (MDR) microbes are resistant to
three or more antibiotics (Styers et al. 2006), however;
strains of Mycobacterium tuberculosis, resistant to virtually
all classes of antimicrobials have also been identified in the
Kwa Zulu Natal Province of South Africa (Gandhi et al.
2006), a typical example of Extremely Drug-Resistant
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Tuberculosis (XDR TB) reported in 64 countries to date
(World Health Organization 2011). The global emergence
of MDRs is increasingly limiting the effectivity of the
existing antibiotic drugs (Hancock 2005) for e.g. methi-
cillin-resistant Staphylococcus aureus (MRSA) and van-
comycin-resistant Enterococci spp. (Norrby et al. 2005).
The development of resistance among the microbes is the
result of continuous selection pressure of antibiotics and
their surroundings causing genetic alterations (Bush 2004)
which, are transferred to the next generation and reach out
to the wider range of other geographical regions through
the transfer of genetic information exchange between
microbes (Ama´bile-Cuevas 2003) (Table 1 presents the
examples of some of the common MDRs). In this review,
attempt has been made to understand specific issues such as
factors causing resistance, the role of developing world
with a quick overview of plant-derived antimicrobials
(PDAm) and synergistic compounds as an alternative drug
line.
Factors causing AMR
Microbes comprise 50 % of total living biomass and are
well-survived life forms on earth. There exists a sharp
distinction between microbes as pathogenic and non-path-
ogenic although; one-way exchange of genetic elements
(Ama´bile-Cuevas 2003) may confer the pathogenic char-
acters to the non-pathogenic microbe. Pathogenic microbes
cause infectious diseases in humans and animals and are
treated with antibiotics. Antibiotics also known as antimi-
crobials are chemical substances, toxic for most of the life
forms. Irrational and deliberate use of antibiotics, migra-
tion of infected individuals to other communities (Memish
et al. 2003), prolonged use of medical health care systems
in hospitals, hunger and malnutrition are some of the main
causes of the development of resistance against antibiotics
in the microbes (Byarugaba 2004; Vila and Pal 2010).
Antimicrobial use in veterinary practices especially as food
additives is one of the causes of development of AMRs in
zoonotics that may spread to humans (Memish et al. 2003)
through the food chain. In this connection, reports of
Schlegelova et al. (2008) suggest, least chances of
spreading of a resistant strain through the dairy products,
however; improperly processed raw meat is strongly dis-
couraged for human consumption in developed nations
(Threlfall 2002).
Molecular understanding of AMR
Microbes attain resistance very rapidly against most of the
currently available antibiotics because of the adaptability
feature conferred by plasmids. Table 1 presents the
examples of such plasmids carrying integron and gene
cassettes in most common MDRs which on transfer,
widespread the resistance (Kumarasamy et al. 2010).
Gram-negative (Kumarasamy et al. 2010) and Gram-posi-
tive bacteria (Grohman et al. 2003) both exhibit conjuga-
tive transfer of plasmids, a natural way of horizontal gene
transfer for e.g. the horizontal transfer of plasmid in
between Vibrio fluvialis and Vibrio cholerae conferring
resistance to V. fluvialis (Rajpara et al. 2009). Recent cases
of AMR development include Pseudomonas aeruginosa
and Acinetobacter baumannii resistant to nearly all
Table 1 Examples of plasmids carrying integron integrase carrying gene cassettes imparting resistance against antimicrobials
Plasmid gene cassette Resistance against Microbes (isolation) Conjugative transfer References
pVN84 MDR Vibrio spp. 4 Rajpara et al. (2009)
MLSB [erm(B) & erm(C)] Erythromycin Staphylococcus spp. 8 Schlegelova et al. (2008)
grlA or gyr A Ciprofloxacin Staphylococcus spp. 8 Campion et al. (2004)
pbp2X b-Lactam Staphylococcus spp. 8 Coffey et al. (1991)
CTX-M
aac(60)-Ib Aminoglycoside Klebsiella pneumoniae 4 Soge et al. (2006)
emr(B) Macrolide-lincosamide-streptogramin B K. pneumoniae 4
pla TEM-1 Ampicillin K. pneumoniae 4
dfr Trimethoprim K. pneumoniae 4
p3iANG
dfrA15 Trimathoprim Vibrio cholerae 4 Ceccarelli et al. (2006)
bla PI b-Lactam V. cholerae 4
qacH Quaternary ammonia-compounds V. cholerae 4
aadA8 aminoglycosides V. cholerae 4
mecA Methicillin (MDR) S. aureus 8 Hiramatsu et al. (2002)
qnr (carried on class 1 integron) Ciprofloxacin V. Cholerae 8 Fonseca et al. (2008)
blaMDL-1 Carbapenem Enterobacteriaceae 4 Kumarasamy et al. (2010)
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antibiotics including the carbanems (Huang and Hsueh
2008). Antibiotic inactivation (degradation of antibiotics
by the microbial enzymes e.g. transferase and b-lactamase)
causes resistance in microbes (Wright 2005; Jacoby and
Munoz-Price 2005), more than 1,000 such b-lactamases are
identified till date (Bush and Fisher 2011). Different anti-
biotics have different mode of actions, therefore, their use
is largely dependent on variety of traits other than resis-
tance (Ama´bile-Cuevas 2010) which either undergo rapid
enzymatic degradation or actively effused by the resistant
bacteria. Efflux pump in MDRs was first described by
Roberts (1996) for tetracycline and macrolide antibiotics.
In general, efflux pumps act through membrane proteins of
substrate specificity, effuse the antibiotics from the bacte-
rial cell, resulting in a low intracellular ineffective con-
centration of the drug (Gibbons 2004; Thorrold et al. 2007)
altering the permeability of membrane. In a study, staph-
ylococcal accessory regulator (sarA) was reported to con-
tribute promising role, imparting resistance in S. aureus
(Riordan et al. 2006). In addition, Kuete et al. (2011)
reported two efflux pumps viz., AcerAB-TolC (Entero-
bacteriaceae) and MexAB-OprM (Pseudomonas aerugin-
osa) imparting resistance in Gram-negative bacteria against
natural products. AMR is a genetically-modified manifes-
tation, linked to the point mutation in bacterial non-chro-
mosomal DNA. As in case of MRSA, the resistance to
methicillin is associated with acquisition of a mobile
genetic element, SCCmec, which contains mecA-resistant
gene (Okuma et al. 2002). Analytical procedure followed
on Escherichia coli showed reversible function of class 1
integron integrase gene machinery under selective pressure
(Dı´az-Mejı´a et al. 2008). Similar results were also observed
by Hsu et al. (2006) whereby E. coli MDR was found
associated with the class 1 integron gene. Detailed mech-
anism of development of AMR among microbes has been
extensively reviewed by Byarugaba (2010).
Developing world: the factory of MDRs
Developing world especially the countries of South East
Asia, Western and Central Africa, India and Pakistan are
the most vulnerable for various infectious pandemic dis-
eases. Byarugaba (2004) comprehensively reviewed and
reported the AMR in developing countries. Several factors
are associated with the AMR development including nos-
ocomial infections, unsafe disposal of biomedical waste,
inappropriately used antibiotics, self drug abuse, shortfall
of antibiotic course and lack of mass awareness of infec-
tious diseases and personal hygiene (Okeke et al. 2005a, b).
In addition to these, lack of surveillance data, providing
information of microbial infections common to a geo-
graphic location and the invasive microbial species have
been suggested as the major causes of MDRs development
in developing countries (Okeke et al. 2005a, b; Giske and
Cornaglia 2010; Kartikeyan et al. 2010; Lalitha et al.
2013). Giske and Cornaglia (2010) emphasized on the
surveillance practices especially the monitoring and sam-
pling techniques of invasive microbial isolates. Surveil-
lance of resistance in many developing countries is
suboptimal (Okeke et al. 2005b) and unable to present the
real picture of infectious diseases and the medication.
Recent reports of Lalitha et al. (2013) showed the feasi-
bility of proper surveillance of resistance by carrying
experimental surveillance study on the school children in
different geographic locations of Indian subcontinent. In
India for Salmonella typhi, MDR has become a norm in
strains. This widespread resistant bacterium is associated
with contaminated water supply in developing countries
and through food products such as contaminated meat in
developed countries (Threlfall 2002). Remarkable report of
Kumarasamy et al. (2010) provides sufficient evidences in
support of the positive role of developing world in the
development of ARMs. Resistance to carbapenem con-
ferred by plasmid encoded New Delhi metallo-b-lacta-
mase-1 (blaNDM-1) is a worldwide health problem,
especially in UK, (Kumarasamy et al. 2010) having the
roots in India and Pakistan. The selective pressure on the
bacterial cells is associated with the adaptations causing
resistance among microbes for multiple antimicrobials for
e.g. genes encoding NDM-1, OXA-23 and OXA-51
enzymes (hydrolyzing specific antibiotics) were observed
in three different isolates of Acinetobacter baumannii in
India (Kartikeyan et al. 2010). Alterations in gene structure
were reported in A. baumannii as a result of selection
pressure of antibiotics (Kartikeyan et al. 2010). The liter-
ature suggest, substandard surveillance of resistance, non-
prescribed antibiotic usage causes huge selection pressure
resulting in the development of AMR in developing
countries and their suburbs (Byarugaba 2004; Okeke et al.
2005b; Kumarasamy et al. 2010). Figure 1 shows a sche-
matic diagram showing the development of MDR microbe
in community.
Plants derived antimicrobial (PDAm): a ray of hope
Antimicrobial resistance is rapidly increasing along with
the development of classical antibiotics consequently, there
is an urgent need to develop a different drug line to treat and
control MDR bacterial infections. Medicinal values of
plants were known to earlier traditional medical practitio-
ners (Emeka et al. 2012). PDAm substances are plant-
originated secondary metabolites and have great concern
because of their antibiotic activity without conferring
resistance (Baris et al. 2006; Palaniappan and Holley 2010).
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PDAms are classified as antimicrobial on the basis of dose
ranging from 100 to 1,000 lg ml-1 for the minimum
inhibitory concentration (MIC) susceptibility test per-
formed on bacteria (Tegos et al. 2002). Table 2 presents
few of the examples of plants and their active antimicrobial
compounds. Plants have unlimited ability to produce wide
variety of secondary metabolites most of which are aro-
matic compounds including alkaloids, glycosides, terpe-
noids, saponins, steroids, flavonoids, tannins, quinones and
coumarins (Das et al. 2010) forming the basis of PDAm
compounds (Table 3). Target specific plant’s secondary
metabolites having potential to treat and control the infec-
tions are being screened out globally for e.g. Coumarins
having specificity on Staphylococcus aureus and ineffective
on Gram-negative bacteria (Lewis and Ausubel 2006). The
literature such as Cowan (1999); Lewis and Ausubel (2006)
and Gonza´lez-Lomothe et al. (2009) provides comprehen-
sive information on the major secondary metabolites of
plant origin. Precise mechanistic approach of PDAm and
their activity on microbes has been discussed by Lewis and
Ausubel (2006). In general, PDAms (mostly secondary
metabolites) are phenol derivatives, sufficiently able to
control microbes by reducing pH, increasing membrane
permeability, altering efflux pumping. Examples mentioned
in Table 2 followed by recent studies of (Machado et al.
2003; Ram et al. 2004; McGaw et al. 2008; Renisheya et al.
2011; Ahmed et al. 2012; Emeka et al. 2012; Upadhyaya
2013) and the references there in, suggest the antimicrobial
potential of various local and exotic plant species, although
very few reports have suggested the mechanism of their
actions. The affectivity of PDAms largely depends upon the
extraction methods (Das et al. 2010). In a study carried out
by our group, methanolic, ethanolic and water extracts of
several plants species viz., Argemone maxicana, Callisto-
mon lanceolatus, Allium sativum, Swietenia mahogany,
Citrulus colocynthis, Salvadora persica, Madhuca Indica,
Acacia nilotica and Pongamia pinnata were assayed for
their antimicrobial activity on most of the common MDRs
viz., Staphylococcus aureus, Bacillus cereus, B. pumilus,
Klebsiella pneumonia, Salmonella typhi, E. coli exhibiting
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Fig. 1 Illustrative sketch of the development of MDR microbes. The
sketch is divided into various segments: (1) Bacterial infection was
treated with calculated amount of antimicrobial drug (X) followed by
complete cure, in the same time prolonged use of drug (X) put
selective pressure causing point mutation (D). (2) Second infection (in
a community only) was treated with same drug (X) with a higher dose,
a delayed response was displayed because of mutant bacterial strain,
(3) Third time infection (in a community only) trigger the resistance, in
particular microbe for a particular drug (X); therefore, synergistic
compounds (Y) were administered along with (X) may be for clinical
trials, the successful treatment, leading to the production of new
antimicrobial drug (Z), (4) Since the earlier bacteria attained resistance
in due course of time for the drug (X) transferred the resistant gene into
another strain of same species of bacteria resistant to the drug
(Z) which was introduced in this community from the other one, gene
cassettes got recombined on the plasmid to confer multi-drug resistant
status to the new introduced bacteria. Infection caused by both these
bacteria might be having same symptoms which would be treated with
the newly developed drug (Z) keeping the resistance against (X) in
consideration. (5) Infection could not be cured because the drug was
applied to cure the (X) drug-resistant bacteria however; another
bacteria having resistance against (Z) remained as such
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activity of all the extracts, however; the target specificity of
plant extracts could not be established because of uncertain
mechanism of plant-derived antimicrobial compounds. A
generalized mechanism of PDAms on microbes suggests the
effects of efflux pumping on MDRs: increasing perme-
ability and reduce selection pressure (Lewis and Ausubel
2006). Antimicrobial peptides (AMPs) are also produced by
plants against the infections also called as defensins. Plant
defensins are small basic peptides, having characteristic 3D
folding pattern, stabilized by eight disulfide linked cysteines
(Thomma et al. 2002). AMPs have antimicrobial properties
too (Li et al. 2012) and have been suggested as an alter-
native approach to improve treatment outcome (Brouwer
et al. 2011), for e.g. IbAMP1, a plant originated disulfide
linked b-sheet antimicrobial peptide (Wang et al. 2009).
Synergistic actions of PDAms
The AMR is conferred by several factors which have
already been reviewed in previous sections. Plasmid
encoded resistance facilitate bacterial cells to develop
resistance of various degrees. For instance, unlike Gram-
positive, MDR Gram-negative bacterial species have
developed a sophisticated permeability barrier as outer
membrane comprised of hydrophilic lipopolysaccharide
restricting the entry of hydrophobic (quinones and alka-
loids) and amphipathic antibiotic compounds (Lewis and
Ausubel 2006). The biased effect of PDAms on Gram-
positive and -negative species has been a key to the dis-
covery of the synergistic compounds of plant origin (Lewis
2001). Plant antimicrobials act well in combinations with
other amphipathic compounds. In addition to this, resis-
tance in MDRs conferred by efflux pumping can be treated
with the synergistic combinations of antimicrobial with an
efflux pump inhibitor (EPI) and altering outer membrane
permeability of MDR bacteria providing an effective drug
(Savage 2001; Gibbons 2004; Baskaran et al. 2009).
Studies of Chusri et al. (2009) reported another example of
synergistic effect of plant-derived phenolics such as Ellagic
acid (a derivative of Gallic acid) a non-antimicrobial,
administered as EPI in combination with classical antibi-
otic to control Acinetobacter baumannii. Another example
belongs to the well-studied plant Berberis fremontii and its
Table 2 Plant derivatives as antimicrobial for the treatment of microbial infections
Plants Plant derivatives Effective against References
Medicago sativa Saponins, canavanine Enterococcus faecium Staphylococcus aureus Aliahmadi et al. (2012)
Onobrychis sativa AMPs (antimicrobial peptides) E. faecium, S. aureus Aliahmadi et al. (2012)
Allium sativum Organosulfur compounds
(phenolic compounds)
Campylobacter jejuni Lu et al. (2011)
Raphanus sativum RsAFP2 (Antifungal peptide) Candida albicans Aerts et al. (2009)
Vetiveria zizanioides L. Nash Vetivone (vetiver oil) Enterobacter spp. Srivastava et al. (2007)
Chelidonium majus Glycoprotein B. cereus, Staphylococcus spp. Janovska et al. (2003)
Sanguisorba officinalis Alkaloids, antimicrobial peptides Ps. aeruginosa, E. coli Janovska et al. (2003)
Cinnamomum osmophloeum Cinnamaldehyde (in essential oil) Legionella pneumophila Chang et al. (2008)
Ocimum basilicum Essential oil Salmonella typhi Wan et al. (1998)
Micromeria nervosa Ethanolic extract Proteus vulgaris Ali-Shtayeh et al. (1997)
Rabdosia trichocarpa Trichorabdal A Helicobacter pylori Kadota et al. (1997)
Melaleuca alternifolia and
Eucalyptus sp.
Essential oil Staphylococcus spp. and Streptococcus spp. Warnke et al. (2009)
Anthrocephalous cadamba
and Pterocarpus santalinus
Ethanolic extract MDRsM Dubey et al. (2012)
Lantana camara L. Leaf extract in dichloromethane &
methanol
MDRsG ? ve and MDRsG-ve Dubey and Padhy (2013)
Butea monosperma Lam. Ethanolic and hot water extract of leaf MDRsM Sahu and Padhy (2013)
Jatropha curcas (Linn.) Ethanolic and methanolic extract MDRsG ? ve ? Micrococcus sp. &
MDRsG-ve ? Shigella sp. ? Bacillus sp.
Igbinosa et al. (2009)
Ficus exasperate and Nauclea
latifolia
Methanolic extract of leaf and
stem
E. coli, Shigella dysenteriae, S. typhi,
C. albicans, P. aeruginosa
Tekwu et al. (2012)
Rhus coriaria Ethanolic extract MDR P. aeruginosa Adwan et al. (2010)
MDRsM = Staphylococcus aureus ? Acinetobacter sp. ? Citrobacter freundii ? Chromobacterium violaceum ? Escherichia coli ? Klebsiella
sp. ? Proteus sp. ? Pseudomonas aeruginosa ? Salmonella typhi ? Vibrio cholera; MDRsG ? ve = S. aureus (MRSA) ? Streptococcus pyoge-
nes ? Enterococcus faecalis (VRE); MDRsG-ve = Acinetobacter baumannii ? Citrobacter freundii ? Proteus mirabilis ? Proteus vulgaris ? Pseudo-
monas aeruginosa
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amphipathic cation berberine inhibits the NorA MDR
pump of Staphylococcus aureus when applied in combi-
nation with 50-MHC (50-methoxyhydnocarpin, an amphi-
pathic weak acid) a real inhibitor of the pump enhancing
the activity of berberine (Stermitz et al. 2000). Similar non-
antimicrobial compounds known to enhance effectivity of
antimicrobials have been discussed by Lewis (2001).
Detailed mechanism of PDAms on MDR S. aureus has been
discussed in the review by Gibbons (2004). Wang et al.
(2009) defined that the role of AMP plant defensin Ib-
AMP1 isolated from plant Impatiens balsamina have a
prime target, intercellular components, forming small
channels that permit the transit of ions or protons across the
bacterial membrane, the same activity was also observed in
the linear analogs of this peptide.
Future studies
Researches on the AMR and alternating drug system are
endless and a lot of scope is there in the field of ethno-
pharmacology. Scientists are working on the development of




Structure Chemical properties Effective on microbes References
Quinones Conjugated cyclic-dione structure with
molecular formula C6H4O2 e.g.











Alkaloids Naturally occurring amines having
nitrogen in heterocyclic ring of
compounds and are the derivative amino
acids e.g. glabradine from tubers of
Stephania glabra
S. aureus, S. mutans, Microsporum





L-Proline derived Monophyllidin from
Zanthoxylum monophyllum




– Lectins are carbohydrate binding proteins
(phytoaglutinin) with MW around
17,000–400,000
E. coli, P. aeruginosa, Enterococcus






Are ubiquitous in plant’s parts, fruits,
seeds, flowers and even honey. Flavones
are hydroxylated phenolics containing
one carbonyl group






Coumarins Coumarins are phenolic substances made
of fused benzene and alpha pyrone ring
forming toxic compounds found in plants
such as Dipteryx odorata, Anthoxanthum
odoratum etc









Isoprene derivatives having a general
formula C10H16 therefore also called as
Isoprenoids. Well-known examples
include menthol
S. viridans, S. aureus, E. coli, B. subtilis,
Shigella sonnei (highly active) P.





Tannins Large polyphenolic compound containing
sufficient hydroxyls and other suitable
groups
S. aureus, S. typhimurium, Moneim et al.
(2007)
Chemical structure given in front of corresponding group of antimicrobials is not to be considered as generalized one, the references are in
correspondence with bacteria
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safe and effective antimicrobials all over the world. Future
studies may involve the development of new plant-derived
synergistic compounds capable of enhancing the activity of
PDAms. A lot of research potential is also there to answer the
questions for e.g. mechanism of resistance in different bac-
terial species, development of XDRs and their control.
Conclusion
AMR is a worldwide problem. Research literatures suggest
that the substandard living in major parts of developing
world is one of the major causes of the development of
resistance among bacteria. The developed world is also
vulnerable of getting widespread infections for e.g. USA is
surrounded by the developing countries having high rates of
resistance development. Nosocomial, water borne, health
care systems and food products especially meats are some
of the most common means of widespread of resistant gene
globally. Thanks to the modern molecular approaches for
making better understanding of the pathways of resistance
development and its remedy. Pharmacologists are devel-
oping new antibiotic drugs to treat and control various
infections, however; the chances of the development of
resistance are equal to the emergence of new drugs. In
addition, research suggest that the combinations of PDAms
and the synergistic compounds work efficiently on resistant
strains ensuring no further resistance development. More-
over; concerted efforts have been solicited by the world
community because poor countries are worst affected by the
antimicrobial resistance and the developed countries are no
longer safe (Dia´z-Granados et al. 2008). In this regard,
PDAms in combination with plant-derived synergistic
compounds may be the cost-effective approach to deal with
global antimicrobial resistance.
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